Since it is essential to develop new strategies to treat AATD and associated diseases, therapeutic strategies are under development to reduce AAT accumulation in the liver and enhance AAT secretion into the blood. The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.